We also sought to determine by immunohistochemistry whether glioblastoma multiforme (GBM) cases, the most aggressive type of glioma, express ADAMTS1 and produce both the intact and the cleaved forms of IGFBP2. The gene discussed is IGFBP2; the disease is central nervous system cancer.